Guanidinosuccinic acid (GSA) has been isolated in substantial quantities from the urine of uremic patients (I). Attempts to form this compound by transamidination from canavanine and arginine to aspartic acid were unsuccessful. A possible pathway has been found for GSA formation. Human liver homogenate splits canavaninosuccinic acid (CSA) to form homoserine and GSA. Optimum pH is at 8.7-8.8. The reaction proceeds best under anaerobic conditions. Reduced lipoic acid must be present for the reaction. NADH, NADPH, GSH, cysteine, ascorbic acid, NaCN, and reduced CoA, dithiothreitol, and BAL cannot be substituted for the Iipoic acid. BAL, NADH, NADPH, and Co act as inhibitors for the reaction. A nondialyzable inhibitor also is present in the liver and can be washed out with water.
IN EARLIER STUDIES, guanidinosuccinic acid (GSA) was found to he present in substantial qualltities in the urine of uremic patients (1) (2) (3) .
This compound was not detected in the urine of normal individuals. With the appearance of GSA in the urine of uremic patients, the amount of guanidinoacetic acid, normally present, was found to be markedly reduced. GSA had not been found! previously in biologic materials, although its possible existence had been postulated (4, .5). This study was initiated with the object of finding a metabolic pathway for the synthesis of GSA in the human and its possible significance Transamidiiiases from bacteria such as E. coli also would not carry out this transamidination to aspartic acid. The experiments with bacteria were performed on the possibility that the GSA arose from the intestinal 'tract in the human. Attempts were then made to synthesize GSA from ureidosuccinic acid using ammonium carbonate, glutamine, and aspartic acid as nitrogen donors, with liver, kidney, heart, and pancreas tissue; these were all unsuccessful.
Incubation of these tissues with glutamine or ammonium carbonate and aspartic acid or asparagine at various pH levels also failed to yield detectable amounts of GSA.
Technics had been developed whereby it was practicable to isolate as little as 5 g of GSA when added to a liter of urine (3). Similarly, 5 .g of guanidinoglutaric acid also could be detected.
In repeated experiments on urine we were able to isolate regularly as much as 50 mg of GSA per liter of urine from a uremic patient, but we could not detect guanidinoglutaric acid. We felt that if a transamidimiation mechanism to aspartic acid existed, it would apply, in some measure, to glutamic acid. We therefore sought another pathway which could be necessarily specific to the production of GSA. Argininosuccinic acid! could conceival)ly split, by ammonolysis, to form ornithine and guanidinosuccinic acid. To test this mechanism, we heated a solution of argininosuccinic acid with concentrated ammonia solution in a sealed glass tube at 100#{176} for 3 hr. The argininosuccinic acid was recovered unchanged, and 110 trace of GSA could be detected. GSA had been formed by catalytic hydrogenation of canavaninosuccinic acid (CSA) to form homoserine and GSA (5). We therefore prepared CSA enzymatically by condensation of canavanine with fumaric acid. Reduction with palladium black and hydrogen at pH 8.0 yielded homoserine, GSA, and a small amount. of aspartic acid, as had i)eefl reported (4).
Conditions
were then studied to explore the posSibility that a system existed in the human which could carry out this reaction. was now adjusted to 6.9 with 1 N HC1 and allowed to stand at room temperature for 40 hr; 1 ml of toluene was added to prevent bacterial growth. The formation of CSA was followed by means of the Sakaguchi reaction.
To 0.75 ml of the incubation mixture was added, with mixing, 0.25 ml of 20% (w/v) trichloracetic acid (TCA). To 0.1 ml of the supernatant solution, after centrifuging, was added 1 ml of water. The test tube was placed in an ice bath; 0.2 ml of 10% (w/v) NaOH was then added, followed by 0.5 ml of the thymine-dichloronaphthol solution, followed by 0. of acetone. The residue was lyophulized for 6 hr to remove acetone and traces of water, and then ground in a mortar.
The yield was 2.5 g.
Unwashed Liver Powder (ULP)
Minced liver, 25 g, was treated as for the dialyzed liver powder except that dialysis was omitted. To 100 mg of dl-6,8-thioctic acid in reduced form (Sigma) that had been weighed out in a small calibrated centrifuge tube was added 4 ml of water.
Assay of CSA-Splitting Activity
Nitrogen gas was bubbled slowly through the mixture, and 250 l of 8% NaOH was added slowly from a micropipet.
When solution was complete, the pH was adjusted to 9.0 with the alkali and the volume made up to 5 ml with water. This was the lipoic acid solution (20 mg/mi).
Liver powder, 25 mg, was added to a test tube in an ice bath, followed by 2 ml of 0.1 M phosphate buffer, pH 8.0. Nitrogen was blown through in a fine stream to deaerate.
After 5 mm, 2 ml of the USA solution was added, followed by 2 ml of lipoic acid solution.
The pH was then adjusted to 8.7 with S-al aliquots of 2% NaOH. The stream of nitrogen also served to stir the mixture. A 0.25-mi aliquot was removed for testing (zero time) with the Sakaguchi reaction.
The nitrogen capillary was removed and the tube quickly stoppered. The tube was then transferred to a 37#{176} water bath and rocked. Samples (0.25 ml) for further tests were removed from time to time with a needle and syringe through the rubber stopper to avoid access of air.
As soon as the 0.25-nil aliquots were removed for testing, 0.1 ml of 20% TCA was added.
The solutions were centrifuged and stored in the refrigerator.
At the end of the test, 0.1-ml aliquots of the supernatant were taken from each of the aliquot tubes, and 1 ml of water was added, followed by the Sakaguchi reagents as described under CSA preparation.
The instrument was adjusted to zero with color developed on 0.1 ml of a 5% TCA solution treated as for the supernatant. A control was tested using 2 ml of buffer plus 25 mg liver powder, 2 ml of lipoic acid solution, and 2 ml of 0.02 M phosphate buffer, pH 7.4, in place of the CSA. In a second control tube 2 ml of buffer plus 25 mg liver powder, 2 ml of the CSA, and 2 ml of the phosphate buffer in place of the lipoic acid solution was used. The pH was adjusted to 8.7 in all tubes.
The standard curve was run using a stock solution of GSA hydrate, 1 mol/ml (19.3 mg/100 ml water). This solution was diluted serially to prepare 'standards ranging down to 0.05 j.mol/ml. The color was developed by adding 0.1 ml of water to 1.0 ml of each solution, developing the Sakaguchi color as before. The amount of GSA generated in each tube was calculated as follows: CSA and GSA both yield color with the Sakaguchi reagent. However, GSA yields 3.5 times the color intensity of CSA with this reagent on a corresponding molar basis ( NaOH solution, 2.4% urea solution, and 0.06% 2-4-dichloro-1-naphthol in 95% ethanol, the three solutions being mixed just before use. The paper was air-dried and then sprayed with NaOBr solution made by dissolving 0.3 ml of bromine in 100 ml of 3% NaOH. The papers were then air-dried.
The stains are pink ill color. The limit of detectability for GSA was 5 /.4g, and for USA 15 g.
For location of guanidine, a diacetyl spray was employed. A solution was prepared by dissolving 200 mg of -naphthol in 20 ml of an alkaline buffer, made up to l)e 6% with respect to NaOH and 16% with respect to Na2CO3. To this was added 20 l of diacetyl from a Sahli pipet. The mixture was used within 30 mm. After spraying, the paper was airdried, and a pink color developed.
The limit of detectability was 1 g
.
Assay for Arginase Activity
Arginase activity was estimated by measuring the rate of liberation of urea from arginine (9).
Assay for ASL Activity
The method described was used, except that 2,4-dichloro-1-naphthol was used in place of -iiaphthol in the Sakaguchi reaction. Activity is expressed as micromoles of arginine liberated from argininosuccinic acid at pH 7.0 per minute per milligram of protein times 1000 (8).
Preparation of GSA
In a hood, 2.6 g of L-aspartic acid was dissolved in 10 ml of water in a 100-ml Erlenmeyer flask. 
Degradation of GSA By Various Tissues
Fresh rabbit, rat, and mouse liver, kidney, pancreas, heart, and mammary gland were homogenized in 0.02 M phosphate buffer at pH 7.4 in the cold room to a concentration of 100 mg of tissue per milliliter. An equal volume of 2 mmol GSA solution in water adjusted to pH 7.4 with 10% NaOH was added. The pH of the mixture was then adjusted to pH 5.0, 6.0, 7.0, 8.0, 9.0, and 9.5 in separate tubes. The tubes were rocked and incubated at 37#{176} for 4 hr. A blank tube containing 1 ml of buffer at the pH levels indicated, in place of the tissue, was used as a control. Protein was then precipitated with 0.5 ml of 20% TCA. A 2-mi volume of supernatant was adjusted to pH 2.2 and adsorbed n an 18-in. column of Dowex 50-X1'2. The column was elute(1 with pH 4.1 acetate buffer as described (1 and each set dissolved in 10 ml of water. These were the samples from the control period. On the next day 100 mg of GSA was suspended in 1 ml of water and adjusted with 5% NaOH to pH 7.4, at which pH the GSA dissolves to a final volume of approximately 2 ml. This solution was injected subcutaneously at two sites in approximately 1-mi portions. The rats were returned to the cages, and urine was collected at 24 hr intervals for 5 days. The five sets were lyophilized and dissolved in 10 ml of water as before.
Aliquots, 1 ml from each set-both control and experimental periods -were fractionated on a Dowex 50-X12 column as above. The GSA recovered was calculated as above.
Results
Figure 2 is a qualitative demonstration of the action of liver extract on USA. In this figure, it is to be noted that at pH 5.0, GSA and CSA both travel to the anode but at different speeds. Both GSA and CSA produce a color with the Sakaguchi reagent.
Only CSA reacts with ninhydrin, as would be expected, since it contains the a-amino acid group.
Homoserine travels to the cathode and yields color with the ninhydrin reagent but not with the Sakaguchi reagent. USA and protein are detected before incubation. After incubation with the preparation extracted from human liver, it can he seen from tile ninhydrin reaction that the CSA has been destroyed, ali(l from the Sakaguchi reaction that the USA has been converted to GSA plus homoserine. The   Fig 2 (opposite) . changed GSA ranged from 90 to 95%. No statistically significant difference was observed from that recovered from the control tubes in any case. In each instance the homogeneity and identity of the GSA recovered was checked by paper electrophoresis.
The results on the intact rats also showed similar results, a mean value of 95% of the GSA being recovered after 5 days (Table  3) . No GSA was detected in the control urine samples.
Discussion
The primary ohective of this study was to 1111(1 11 meellanism for the formation of GSA in the urine of the uremic patient. in this system had to be known so that if it were further metabolized one could seek its metabolic products.
As shown in Table 3 and discussed above, GSA is unchanged both by the intact rat and when incubated with various tissues. Thus, long incubation periods could be used in the study.
The problem then resolved itself to finding a suitable substrate.
CSA was chosen because it had been reduced catalytically by hydrogen with palladium black (5). FT AL Clinical Chemistry They indicate that the action of this enzyme is glucose-dependent. Optimum pH of the culture medium was at 7.0, and aerobic conditions were used.
It is conceivable that these authors were dealing with a system similar to that observed with the liver. This would require the presence of a specific hydrogen donor and an anaerobic atmosphere. The latter might account for the glucose dependence of their system. With an isolated system, lack of knowledge of the requirement for anaerobic conditions and the need for a specific hydrogen donor, possibly lipoic acid, might well explain their inability to carry out this reaction in bacterial extracts.
Canavanine is degraded readily by transamidination to produce canaline and guanidinoamino acids (13) (14) (15) by the action of arginase to produce urea and canaline (16) and by the action of L-arginine iminohydrolase to produce ureidohomoserine and ammonia
(12).
The presence of these enzyme systems, especially the presence of large amounts of arginase in our preparations, may account for the low yield of guanidine.
The reaction is being carried out in the proximity of the optimum pH for arginase. This reaction will be explored further with CSR free of ASL and arginase.
While we have demonstrated that USA can be ruptured by human liver to generate GSA, this observation must be linked with the GSA which appears in the urine of uremic patients. One might argue that canavanine, taken in the food, is condensed with fumaric acid to form CSA. In our studies we have shown that an adequate amount of the USA-condensing enzyme is present in the human kidney for this purpose. The CSA formed then would be split in the liver to GSA and homoserine.
We have shown that, at least in rats, GSA is harmless and seems to be an end product of metabolism (Table 3) .
Canavanine has been shown to be toxic to mice (17) and microorganisms (18, 19) . This would suggest the need for a mechanism to protect the human against canavanine, which is present in certain legumes in very large quantities.
In 
